Skip to main content

James Basta

Equibles does not estimate personal net worth.

Get an email with a short summary when Intellia Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get NTLA alerts

About James Basta

James Basta is recorded as General Counsel at Intellia Therapeutics, Inc. (NTLA). The proxy statement of Intellia Therapeutics, Inc. reports total compensation of $1,846,597 for James Basta in fiscal 2025, including a base salary of $494,000. Disclosed compensation is on record for 5 fiscal years. Intellia Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Intellia Therapeutics, Inc. includes Edward J. Dulac III (CFO), Andrew D. Schiermeier (COO), Michael P. Dube (Chief Accounting Officer) and 7 others.

Affiliation history

Company network

Leadership on record at Intellia Therapeutics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Intellia Therapeutics, Inc. (NTLA) $494,000 $1,846,597
2024 Intellia Therapeutics, Inc. (NTLA) $479,000 $4,872,670
2023 Intellia Therapeutics, Inc. (NTLA) $460,000 $3,994,791
2022 Intellia Therapeutics, Inc. (NTLA) $435,600 $3,625,229
2021 Intellia Therapeutics, Inc. (NTLA) $219,692 $15,072,959

Recent activity

No call appearances or filed executive changes recorded yet.